107 related articles for article (PubMed ID: 10835843)
1. A comparative study of changes in fecal flora in patients preconditioned with either amphotericin B or fluconazole for allogeneic bone marrow transplantation.
Ashida T; Tsubaki K; Hasegawa H; Kanamaru A
Kansenshogaku Zasshi; 2000 Apr; 74(4):365-71. PubMed ID: 10835843
[TBL] [Abstract][Full Text] [Related]
2. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
[TBL] [Abstract][Full Text] [Related]
3. Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. The Bone Marrow Transplantation Team.
Alangaden G; Chandrasekar PH; Bailey E; Khaliq Y
Bone Marrow Transplant; 1994 Dec; 14(6):919-24. PubMed ID: 7711669
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
[TBL] [Abstract][Full Text] [Related]
5. [New quinolone versus vancomycin/tobramycin for intestinal sterilization in patients who undergo allogeneic bone marrow transplantation].
Hosen N; Teshima H; Karasuno T; Ujiie H; Nakao T; Yagi T; Hatanaka K; Kawamoto S; Hiraoka A; Nakamura H; Masaoka T
Rinsho Ketsueki; 1999 Jan; 40(1):9-15. PubMed ID: 10067090
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of yeast colonization and infections in paediatric bone marrow transplant recipients.
Hoppe JE; Klausner M; Klingebiel T; Niethammer D
Mycoses; 1997; 40(1-2):47-54. PubMed ID: 9260481
[TBL] [Abstract][Full Text] [Related]
7. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
[TBL] [Abstract][Full Text] [Related]
8. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
[TBL] [Abstract][Full Text] [Related]
9. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
[TBL] [Abstract][Full Text] [Related]
10. Antifungal prophylaxis in bone marrow transplant.
Lam HH; Althaus BL
Ann Pharmacother; 1995 Sep; 29(9):921-4. PubMed ID: 8547742
[TBL] [Abstract][Full Text] [Related]
11. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
12. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans.
Klepser ME; Wolfe EJ; Pfaller MA
J Antimicrob Chemother; 1998 Mar; 41(3):397-401. PubMed ID: 9578168
[TBL] [Abstract][Full Text] [Related]
13. Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
Gahn B; Schub N; Repp R; Gramatzki M
Eur J Med Res; 2007 Aug; 12(8):337-40. PubMed ID: 17933709
[TBL] [Abstract][Full Text] [Related]
14. Post-antifungal effect and adhesion to buccal epithelial cells of oral Candida dubliniensis isolates subsequent to limited exposure to amphotericin B, ketoconazole and fluconazole.
Ellepola AN; Chandy R; Khan ZU
J Investig Clin Dent; 2015 Aug; 6(3):186-92. PubMed ID: 24850753
[TBL] [Abstract][Full Text] [Related]
15. Infection prevention in autologous bone marrow transplantation and the role of protective isolation.
Dekker AW; Verdonck LF; Rozenberg-Arska M
Bone Marrow Transplant; 1994 Jul; 14(1):89-93. PubMed ID: 7951125
[TBL] [Abstract][Full Text] [Related]
16. Australian Dental Research Fund Trebitsch Scholarship. Efficacy of antifungal prophylaxis in bone marrow transplantation.
Quirk PC; Osborne PJ; Walsh LJ
Aust Dent J; 1995 Aug; 40(4):267-70. PubMed ID: 7575286
[TBL] [Abstract][Full Text] [Related]
17. Successful allogeneic bone marrow transplantation in a patient with active Coccidioidomycosis.
Schriber J; Almond H; Alvarnas J; Sarkadee-Adoo C
Bone Marrow Transplant; 2005 May; 35(9):927-8. PubMed ID: 15778732
[No Abstract] [Full Text] [Related]
18. Efficacy of different prophylactic antifungal regimens in bone marrow transplantation.
Annaloro C; Oriana A; Tagliaferri E; Bertolli V; Della Volpe A; Soligo D; Ibatici A; Pozzoli E; Lambertenghi Deliliers GL
Haematologica; 1995; 80(6):512-7. PubMed ID: 8647515
[TBL] [Abstract][Full Text] [Related]
19. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
20. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
